BREAKING NEWS: CRISPR/Cas9 is at it again
BREAKING NEWS: CRISPR/Cas9 is at it again. No longer content as only a genomic editing tool, CRISPR/Cas9 can also edit the epigenome, per a new study published April 6 in
Nature Biotechnology. The new technology utilizes non-cutting dCas9 protein coupled to a histone-modifying protein, creating a system able to selectively raise levels of gene expression by increasing activity at a variety of regulatory regions.
Enzo’s Newest Antibody:
Monoclonal Antibody Cas9, mAb (7A9)
- Recognizes both Cas9 and dCas9
- Species independent detection
- Validated for IF, IP and WB
- Test additional applications Worry-Free!
Given the new advances, where do you think initial interest will lie? What would you like to edit in the epigenome? Tell us about it!
